Interactions Between the Glutamate and Glycine Recognition Sites of the N-Methyl-d-Aspartate Receptor from Rat Brain, as Revealed from Radioligand Binding Studies-Reference-Cited by-同舟云学术

Interactions Between the Glutamate and Glycine Recognition Sites of the N-Methyl-d-Aspartate Receptor from Rat Brain, as Revealed from Radioligand Binding Studies

Published:1993-05 Issue:5 Volume:60 Page:1729-1738
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J Neurochem

Author:

Grimwood Sarah,Wilde Geraint J. C.,Foster Alam C.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.1993.tb13397.x/fullpdf

Reference47 articles.

1. [3H]5,7-Dichlorokynurenic acid, a novel radioligand labels NMDA receptor-associated glycine binding sites

2. Evidence for a functional coupling of the NMDA and glycine recognition sites in synaptic plasma membranes

3. Kynurenate and 2-amino-5-phosphonovalerate interact with multiple binding sites of the glutamate receptor domain

4. [3H]D-serine labels strychnine-insensitive glycine recognition sites of rat central nervous system

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Characterization of [18F]-FNM and Evaluation of NMDA Receptors Activation in a Rat Brain Injury Model;Molecular Imaging and Biology;2023-03-21

2. Heteromerization of Ligand Binding Domains of N-Methyl-d-Aspartate Receptor Requires Both Coagonists, l-Glutamate and Glycine;Biochemistry;2015-01-08

3. Drug Design, in Vitro Pharmacology, and Structure−Activity Relationships of 3-Acylamino-2-aminopropionic Acid Derivatives, a Novel Class of Partial Agonists at the Glycine Site on the N-Methyl-d-aspartate (NMDA) Receptor Complex;Journal of Medicinal Chemistry;2009-07-30

4. Role of the glycine site of theN-methyl-d-aspartate receptor in synaptic plasticity induced by pairing;European Journal of Neuroscience;2005-05

5. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development;Psychopharmacology;2003-09-01